,,iv  #aacth ,,congress  #ast ,session  
,h4 ,,res4 #adi  ,,in ,,the ,,house ,,of
 ,,representatives  ,april #aj1 #bjac   
,mrs4 ,carolyn ,b4 ,maloney of ,new     
,york 7for herself1 ,mr4 ,king of ,new  
,york1 and ,mr4 ,van ,hollen7 submitted 
the following resolution2 which was     
referred to the ,committee on ,energy   
and ,commerce  ,,resolution  ,expressing
 support for designation of ,april as   
,parkinson's ,awareness ,month4         
,whereas ,parkinson's disease is a      
chronic1 progressive1 neurological      
disease and is the second most common   
neurological disease in the ,united     
,states2 ,whereas there is inadequate   
comprehensive data on the incidence and 
prevalence of ,parkinson's disease2     
,whereas it is estimated that the       
disease affects #ejj1jjj to #a1ejj1jjj  
people in the ,united ,states and the   
prevalence will more than double by     
#bjdj2 ,whereas there are millions of   
people in the ,united ,states who are   
caregivers1 family members1 and friends 

greatly impacted by ,parkinson's disease
 every day2 ,whereas it is estimated    
that the economic burden of ,parkinson's
 disease is #ad1djj1jjj1jjj including   
indirect costs to patients and family   
members of #f1cjj1jjj1jjj each year2    
,whereas although research suggests the 
cause of ,parkinson's disease is a      
combination of genetic and environmental
 factors1 the exact cause and           
progression of the disease is still     
unknown2 ,whereas there is no objective 
test or biomarker for ,parkinson's      
disease1 and the rate of misdiagnosis   
can be high2 ,whereas the symptoms of   
,parkinson's disease vary from person to
 person and include tremors1 slowness of
 movement1 difficulty with balance1     
swallowing1 chewing1 speaking1 rigidity1
 cognitive impairment1 dementia1 mood   
disorders 7such as depression and       
anxiety7 constipation1 skin problems1   
and sleep difficulties2 ,whereas there  
is no cure1 therapy1 or drug to slow or 
halt the progression of ,parkinson's    

disease2 ,whereas medications mask some 
symptoms of ,parkinson's disease for a  
limited amount of time each day1 often  
with dose-limiting side effects1 and    
ultimately lose their effectiveness1    
leaving the person unable to move1      
speak1 or swallow2 ,whereas increased   
education and research are needed to    
find more effective treatments with     
fewer side effects and1 ultimately1 an  
effective treatment or cure for         
,parkinson's disease2 and ,whereas      
,april would be an appropriate month to 
designate as ,parkinson's ,awareness    
,month3 ,now1 therefore1 be it  ,that   
the ,house of ,representatives--  7#a7  
supports the designation of ,parkinson's
 ,awareness ,month2  7#b7 supports the  
goals and ideals of ,parkinson's        
,awareness ,month2  7#c7 continues to   
support research to find better         
treatments1 and eventually1 a cure for  
,parkinson's disease2  7#d7 recognizes  
the people living with ,parkinson's who 
participate in vital clinical trials to 

advance the knowledge of the disease2   
and  7#e7 commends the dedication of    
,state1 local1 regional1 and national   
organizations1 volunteers1 researchers1 
and millions of people in the ,united   
,states working to improve the quality  
of life of persons living with          
,parkinson's disease and their families4